nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.139	0.202	CbGbCtD
Minocycline—SLC22A11—Zidovudine—acquired immunodeficiency syndrome	0.137	0.198	CbGbCtD
Minocycline—SLC22A7—Zidovudine—acquired immunodeficiency syndrome	0.131	0.189	CbGbCtD
Minocycline—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.106	0.153	CbGbCtD
Minocycline—SLC22A8—Zidovudine—acquired immunodeficiency syndrome	0.0797	0.115	CbGbCtD
Minocycline—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.0555	0.0803	CbGbCtD
Minocycline—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.0429	0.0622	CbGbCtD
Minocycline—CASP3—alveolus of lung—acquired immunodeficiency syndrome	0.026	0.158	CbGeAlD
Minocycline—CASP3—nerve—acquired immunodeficiency syndrome	0.00573	0.0349	CbGeAlD
Minocycline—CYCS—blood plasma—acquired immunodeficiency syndrome	0.00506	0.0308	CbGeAlD
Minocycline—CASP3—endothelium—acquired immunodeficiency syndrome	0.00488	0.0297	CbGeAlD
Minocycline—CASP3—blood plasma—acquired immunodeficiency syndrome	0.00433	0.0264	CbGeAlD
Minocycline—IL1B—endothelium—acquired immunodeficiency syndrome	0.0039	0.0238	CbGeAlD
Minocycline—IL1B—blood plasma—acquired immunodeficiency syndrome	0.00346	0.0211	CbGeAlD
Minocycline—MMP9—endothelium—acquired immunodeficiency syndrome	0.00325	0.0198	CbGeAlD
Minocycline—MMP9—blood plasma—acquired immunodeficiency syndrome	0.00288	0.0176	CbGeAlD
Minocycline—CYCS—Gemcitabine—Lamivudine—acquired immunodeficiency syndrome	0.00284	1	CbGdCrCtD
Minocycline—CYCS—retina—acquired immunodeficiency syndrome	0.00277	0.0169	CbGeAlD
Minocycline—CASP1—skin of body—acquired immunodeficiency syndrome	0.00253	0.0154	CbGeAlD
Minocycline—CYCS—skin of body—acquired immunodeficiency syndrome	0.00243	0.0148	CbGeAlD
Minocycline—CASP3—retina—acquired immunodeficiency syndrome	0.00237	0.0145	CbGeAlD
Minocycline—CASP3—skin of body—acquired immunodeficiency syndrome	0.00208	0.0127	CbGeAlD
Minocycline—CASP1—lymphoid tissue—acquired immunodeficiency syndrome	0.00204	0.0125	CbGeAlD
Minocycline—CASP1—digestive system—acquired immunodeficiency syndrome	0.00202	0.0123	CbGeAlD
Minocycline—CYCS—lymphoid tissue—acquired immunodeficiency syndrome	0.00197	0.012	CbGeAlD
Minocycline—CYCS—digestive system—acquired immunodeficiency syndrome	0.00194	0.0119	CbGeAlD
Minocycline—CASP1—blood—acquired immunodeficiency syndrome	0.00192	0.0117	CbGeAlD
Minocycline—CASP1—bone marrow—acquired immunodeficiency syndrome	0.00186	0.0114	CbGeAlD
Minocycline—CASP1—spinal cord—acquired immunodeficiency syndrome	0.00185	0.0113	CbGeAlD
Minocycline—CYCS—blood—acquired immunodeficiency syndrome	0.00185	0.0113	CbGeAlD
Minocycline—CYCS—bone marrow—acquired immunodeficiency syndrome	0.00179	0.0109	CbGeAlD
Minocycline—CYCS—spinal cord—acquired immunodeficiency syndrome	0.00178	0.0109	CbGeAlD
Minocycline—CASP1—vagina—acquired immunodeficiency syndrome	0.00178	0.0109	CbGeAlD
Minocycline—CASP1—lung—acquired immunodeficiency syndrome	0.00169	0.0103	CbGeAlD
Minocycline—CASP3—lymphoid tissue—acquired immunodeficiency syndrome	0.00169	0.0103	CbGeAlD
Minocycline—CASP3—digestive system—acquired immunodeficiency syndrome	0.00167	0.0102	CbGeAlD
Minocycline—IL1B—skin of body—acquired immunodeficiency syndrome	0.00166	0.0101	CbGeAlD
Minocycline—CYCS—lung—acquired immunodeficiency syndrome	0.00162	0.0099	CbGeAlD
Minocycline—CASP3—blood—acquired immunodeficiency syndrome	0.00159	0.00967	CbGeAlD
Minocycline—CASP1—nervous system—acquired immunodeficiency syndrome	0.00156	0.00952	CbGeAlD
Minocycline—CASP3—bone marrow—acquired immunodeficiency syndrome	0.00154	0.00936	CbGeAlD
Minocycline—CASP3—spinal cord—acquired immunodeficiency syndrome	0.00153	0.00932	CbGeAlD
Minocycline—CASP1—central nervous system—acquired immunodeficiency syndrome	0.0015	0.00917	CbGeAlD
Minocycline—CYCS—nervous system—acquired immunodeficiency syndrome	0.0015	0.00917	CbGeAlD
Minocycline—CASP3—vagina—acquired immunodeficiency syndrome	0.00147	0.00897	CbGeAlD
Minocycline—Methacycline—ALB—acquired immunodeficiency syndrome	0.00146	0.695	CrCbGaD
Minocycline—CYCS—central nervous system—acquired immunodeficiency syndrome	0.00145	0.00883	CbGeAlD
Minocycline—CASP3—lung—acquired immunodeficiency syndrome	0.00139	0.00848	CbGeAlD
Minocycline—MMP9—skin of body—acquired immunodeficiency syndrome	0.00139	0.00845	CbGeAlD
Minocycline—IL1B—lymphoid tissue—acquired immunodeficiency syndrome	0.00135	0.00821	CbGeAlD
Minocycline—IL1B—digestive system—acquired immunodeficiency syndrome	0.00133	0.00811	CbGeAlD
Minocycline—CASP3—nervous system—acquired immunodeficiency syndrome	0.00129	0.00785	CbGeAlD
Minocycline—IL1B—blood—acquired immunodeficiency syndrome	0.00127	0.00773	CbGeAlD
Minocycline—CASP3—central nervous system—acquired immunodeficiency syndrome	0.00124	0.00756	CbGeAlD
Minocycline—IL1B—bone marrow—acquired immunodeficiency syndrome	0.00123	0.00748	CbGeAlD
Minocycline—IL1B—spinal cord—acquired immunodeficiency syndrome	0.00122	0.00744	CbGeAlD
Minocycline—VEGFA—bone marrow—acquired immunodeficiency syndrome	0.00121	0.00735	CbGeAlD
Minocycline—VEGFA—spinal cord—acquired immunodeficiency syndrome	0.0012	0.00732	CbGeAlD
Minocycline—CASP1—brain—acquired immunodeficiency syndrome	0.00119	0.00728	CbGeAlD
Minocycline—IL1B—vagina—acquired immunodeficiency syndrome	0.00117	0.00716	CbGeAlD
Minocycline—VEGFA—vagina—acquired immunodeficiency syndrome	0.00116	0.00705	CbGeAlD
Minocycline—CASP1—lymph node—acquired immunodeficiency syndrome	0.00115	0.00703	CbGeAlD
Minocycline—CYCS—brain—acquired immunodeficiency syndrome	0.00115	0.00701	CbGeAlD
Minocycline—MMP9—lymphoid tissue—acquired immunodeficiency syndrome	0.00112	0.00684	CbGeAlD
Minocycline—IL1B—lung—acquired immunodeficiency syndrome	0.00111	0.00677	CbGeAlD
Minocycline—CYCS—lymph node—acquired immunodeficiency syndrome	0.00111	0.00677	CbGeAlD
Minocycline—MMP9—digestive system—acquired immunodeficiency syndrome	0.00111	0.00676	CbGeAlD
Minocycline—VEGFA—lung—acquired immunodeficiency syndrome	0.00109	0.00666	CbGeAlD
Minocycline—MMP9—blood—acquired immunodeficiency syndrome	0.00106	0.00644	CbGeAlD
Minocycline—SLC22A11—digestive system—acquired immunodeficiency syndrome	0.00105	0.00641	CbGeAlD
Minocycline—IL1B—nervous system—acquired immunodeficiency syndrome	0.00103	0.00627	CbGeAlD
Minocycline—SLC22A7—digestive system—acquired immunodeficiency syndrome	0.00103	0.00625	CbGeAlD
Minocycline—MMP9—bone marrow—acquired immunodeficiency syndrome	0.00102	0.00623	CbGeAlD
Minocycline—MMP9—spinal cord—acquired immunodeficiency syndrome	0.00102	0.0062	CbGeAlD
Minocycline—IL1B—central nervous system—acquired immunodeficiency syndrome	0.000991	0.00604	CbGeAlD
Minocycline—CASP3—brain—acquired immunodeficiency syndrome	0.000984	0.006	CbGeAlD
Minocycline—CASP3—lymph node—acquired immunodeficiency syndrome	0.000951	0.0058	CbGeAlD
Minocycline—MMP9—lung—acquired immunodeficiency syndrome	0.000926	0.00565	CbGeAlD
Minocycline—ALOX5—lymphoid tissue—acquired immunodeficiency syndrome	0.000887	0.00541	CbGeAlD
Minocycline—ALOX5—digestive system—acquired immunodeficiency syndrome	0.000877	0.00534	CbGeAlD
Minocycline—MMP9—nervous system—acquired immunodeficiency syndrome	0.000857	0.00523	CbGeAlD
Minocycline—ALOX5—blood—acquired immunodeficiency syndrome	0.000835	0.00509	CbGeAlD
Minocycline—MMP9—central nervous system—acquired immunodeficiency syndrome	0.000825	0.00503	CbGeAlD
Minocycline—ALOX5—bone marrow—acquired immunodeficiency syndrome	0.000808	0.00493	CbGeAlD
Minocycline—IL1B—brain—acquired immunodeficiency syndrome	0.000786	0.00479	CbGeAlD
Minocycline—VEGFA—brain—acquired immunodeficiency syndrome	0.000774	0.00472	CbGeAlD
Minocycline—IL1B—lymph node—acquired immunodeficiency syndrome	0.00076	0.00463	CbGeAlD
Minocycline—VEGFA—lymph node—acquired immunodeficiency syndrome	0.000747	0.00456	CbGeAlD
Minocycline—ALOX5—lung—acquired immunodeficiency syndrome	0.000732	0.00446	CbGeAlD
Minocycline—ALOX5—nervous system—acquired immunodeficiency syndrome	0.000678	0.00413	CbGeAlD
Minocycline—MMP9—brain—acquired immunodeficiency syndrome	0.000655	0.004	CbGeAlD
Minocycline—ALOX5—central nervous system—acquired immunodeficiency syndrome	0.000653	0.00398	CbGeAlD
Minocycline—Tetracycline—ALB—acquired immunodeficiency syndrome	0.000639	0.305	CrCbGaD
Minocycline—MMP9—lymph node—acquired immunodeficiency syndrome	0.000633	0.00386	CbGeAlD
Minocycline—SLC22A7—brain—acquired immunodeficiency syndrome	0.000606	0.0037	CbGeAlD
Minocycline—SLC22A6—brain—acquired immunodeficiency syndrome	0.000585	0.00357	CbGeAlD
Minocycline—SLC22A8—blood—acquired immunodeficiency syndrome	0.000565	0.00344	CbGeAlD
Minocycline—MMP9—AP-1 transcription factor network—IL4—acquired immunodeficiency syndrome	0.000553	0.00394	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—CCL5—acquired immunodeficiency syndrome	0.00055	0.00392	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—CCR5—acquired immunodeficiency syndrome	0.000548	0.00391	CbGpPWpGaD
Minocycline—IL1B—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	0.000541	0.00386	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—IFNA1—acquired immunodeficiency syndrome	0.000541	0.00386	CbGpPWpGaD
Minocycline—IL1B—Monoamine Transport—TNF—acquired immunodeficiency syndrome	0.000527	0.00376	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—CCR2—acquired immunodeficiency syndrome	0.000525	0.00375	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	0.000524	0.00374	CbGpPWpGaD
Minocycline—CYCS—Ceramide signaling pathway—TNF—acquired immunodeficiency syndrome	0.000522	0.00372	CbGpPWpGaD
Minocycline—ALOX5—brain—acquired immunodeficiency syndrome	0.000518	0.00316	CbGeAlD
Minocycline—IL1B—Signaling by Interleukins—CSF2—acquired immunodeficiency syndrome	0.000518	0.00369	CbGpPWpGaD
Minocycline—CASP3—Amyotrophic lateral sclerosis (ALS)—TNF—acquired immunodeficiency syndrome	0.000508	0.00362	CbGpPWpGaD
Minocycline—IL1B—IL27-mediated signaling events—IL6—acquired immunodeficiency syndrome	0.000502	0.00358	CbGpPWpGaD
Minocycline—ALOX5—lymph node—acquired immunodeficiency syndrome	0.000501	0.00305	CbGeAlD
Minocycline—IL1B—Folate Metabolism—ALB—acquired immunodeficiency syndrome	0.0005	0.00357	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—IFNA1—acquired immunodeficiency syndrome	0.000494	0.00352	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—IFNG—acquired immunodeficiency syndrome	0.000493	0.00351	CbGpPWpGaD
Minocycline—IL1B—Cytokines and Inflammatory Response—IL6—acquired immunodeficiency syndrome	0.000487	0.00348	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—ACTG1—acquired immunodeficiency syndrome	0.000483	0.00345	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.000477	0.00341	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—CD4—acquired immunodeficiency syndrome	0.000476	0.00339	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	0.000474	0.00338	CbGpPWpGaD
Minocycline—IL1B—IL23-mediated signaling events—TNF—acquired immunodeficiency syndrome	0.000469	0.00335	CbGpPWpGaD
Minocycline—CASP3—TWEAK Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000469	0.00334	CbGpPWpGaD
Minocycline—CASP3—FAS pathway and Stress induction of HSP regulation—TNF—acquired immunodeficiency syndrome	0.000469	0.00334	CbGpPWpGaD
Minocycline—SLC22A8—nervous system—acquired immunodeficiency syndrome	0.000459	0.0028	CbGeAlD
Minocycline—IL1B—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	0.000456	0.00326	CbGpPWpGaD
Minocycline—CYCS—Caspase Cascade in Apoptosis—TNF—acquired immunodeficiency syndrome	0.000455	0.00325	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	0.000448	0.00319	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—IL10—acquired immunodeficiency syndrome	0.000448	0.00319	CbGpPWpGaD
Minocycline—SLC22A8—central nervous system—acquired immunodeficiency syndrome	0.000441	0.00269	CbGeAlD
Minocycline—IL1B—IL12-mediated signaling events—IL2—acquired immunodeficiency syndrome	0.000438	0.00312	CbGpPWpGaD
Minocycline—CASP1—Signaling by Interleukins—IL2—acquired immunodeficiency syndrome	0.000438	0.00312	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	0.000437	0.00312	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—IL4—acquired immunodeficiency syndrome	0.000435	0.00311	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.000431	0.00307	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—CCL5—acquired immunodeficiency syndrome	0.000429	0.00306	CbGpPWpGaD
Minocycline—MMP9—Matrix Metalloproteinases—TNF—acquired immunodeficiency syndrome	0.000426	0.00304	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	0.000426	0.00304	CbGpPWpGaD
Minocycline—CASP3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—acquired immunodeficiency syndrome	0.000408	0.00291	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—IL2—acquired immunodeficiency syndrome	0.000406	0.00289	CbGpPWpGaD
Minocycline—MMP9—amb2 Integrin signaling—TNF—acquired immunodeficiency syndrome	0.000404	0.00288	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.000397	0.00284	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	0.000395	0.00282	CbGpPWpGaD
Minocycline—IL1B—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	0.000394	0.00281	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—MBL2—acquired immunodeficiency syndrome	0.000392	0.0028	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.00039	0.00278	CbGpPWpGaD
Minocycline—CASP1—Apoptosis—TNF—acquired immunodeficiency syndrome	0.00039	0.00278	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—IL2—acquired immunodeficiency syndrome	0.000388	0.00277	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—CSF2—acquired immunodeficiency syndrome	0.000387	0.00276	CbGpPWpGaD
Minocycline—IL1B—IL23-mediated signaling events—IL6—acquired immunodeficiency syndrome	0.000379	0.0027	CbGpPWpGaD
Minocycline—CASP3—TWEAK Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000378	0.0027	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—HLA-B—acquired immunodeficiency syndrome	0.000372	0.00265	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000367	0.00262	CbGpPWpGaD
Minocycline—CASP3—Caspase Cascade in Apoptosis—TNF—acquired immunodeficiency syndrome	0.000367	0.00262	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	0.000364	0.0026	CbGpPWpGaD
Minocycline—IL1B—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	0.000363	0.00259	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—ACTG1—acquired immunodeficiency syndrome	0.000363	0.00259	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.000363	0.00259	CbGpPWpGaD
Minocycline—IL1B—Hematopoietic Stem Cell Differentiation—IL6—acquired immunodeficiency syndrome	0.000356	0.00254	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—IL2—acquired immunodeficiency syndrome	0.000351	0.00251	CbGpPWpGaD
Minocycline—SLC22A8—brain—acquired immunodeficiency syndrome	0.00035	0.00214	CbGeAlD
Minocycline—CYCS—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	0.00035	0.0025	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—CD4—acquired immunodeficiency syndrome	0.000344	0.00245	CbGpPWpGaD
Minocycline—CASP3—Corticotropin-releasing hormone—IL2—acquired immunodeficiency syndrome	0.000344	0.00245	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—IFNG—acquired immunodeficiency syndrome	0.000337	0.0024	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.000335	0.00239	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—IFNG—acquired immunodeficiency syndrome	0.000334	0.00238	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TNF—acquired immunodeficiency syndrome	0.000334	0.00238	CbGpPWpGaD
Minocycline—MMP9—amb2 Integrin signaling—IL6—acquired immunodeficiency syndrome	0.000326	0.00233	CbGpPWpGaD
Minocycline—MMP9—TWEAK Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000325	0.00232	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	0.000317	0.00226	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—ACTG1—acquired immunodeficiency syndrome	0.000315	0.00225	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—IFNG—acquired immunodeficiency syndrome	0.000315	0.00225	CbGpPWpGaD
Minocycline—CYCS—Metabolism—TAT—acquired immunodeficiency syndrome	0.000312	0.00223	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IFNA1—acquired immunodeficiency syndrome	0.000309	0.0022	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CCR2—acquired immunodeficiency syndrome	0.000308	0.00219	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.000306	0.00218	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—IL2—acquired immunodeficiency syndrome	0.000299	0.00214	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—IL2—acquired immunodeficiency syndrome	0.000297	0.00212	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—TNF—acquired immunodeficiency syndrome	0.000295	0.00211	CbGpPWpGaD
Minocycline—IL1B—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	0.000293	0.00209	CbGpPWpGaD
Minocycline—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—acquired immunodeficiency syndrome	0.000291	0.00207	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	0.000287	0.00205	CbGpPWpGaD
Minocycline—VEGFA—Platelet degranulation—ALB—acquired immunodeficiency syndrome	0.000286	0.00204	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—TNF—acquired immunodeficiency syndrome	0.000283	0.00202	CbGpPWpGaD
Minocycline—CASP3—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	0.000283	0.00202	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	0.000282	0.00201	CbGpPWpGaD
Minocycline—MMP9—CXCR4-mediated signaling events—CD4—acquired immunodeficiency syndrome	0.000279	0.00199	CbGpPWpGaD
Minocycline—CASP1—Immune System—ACTG1—acquired immunodeficiency syndrome	0.000278	0.00198	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	0.000277	0.00198	CbGpPWpGaD
Minocycline—IL1B—Signaling by Interleukins—IL2—acquired immunodeficiency syndrome	0.000274	0.00195	CbGpPWpGaD
Minocycline—VEGFA—Response to elevated platelet cytosolic Ca2+—ALB—acquired immunodeficiency syndrome	0.000272	0.00194	CbGpPWpGaD
Minocycline—VEGFA—VEGFR2 mediated cell proliferation—IL6—acquired immunodeficiency syndrome	0.00027	0.00193	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TNF—acquired immunodeficiency syndrome	0.000269	0.00192	CbGpPWpGaD
Minocycline—CYCS—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000265	0.00189	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	0.000263	0.00188	CbGpPWpGaD
Minocycline—VEGFA—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	0.000263	0.00187	CbGpPWpGaD
Minocycline—MMP9—TWEAK Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000263	0.00187	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.00026	0.00185	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	0.000259	0.00185	CbGpPWpGaD
Minocycline—CASP1—Signaling by Interleukins—IL6—acquired immunodeficiency syndrome	0.000257	0.00184	CbGpPWpGaD
Minocycline—IL1B—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	0.000256	0.00183	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—TNF—acquired immunodeficiency syndrome	0.000256	0.00183	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	0.000255	0.00182	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.00025	0.00179	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—CSF2—acquired immunodeficiency syndrome	0.000242	0.00172	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—IL6—acquired immunodeficiency syndrome	0.000238	0.0017	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000236	0.00169	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.000235	0.00167	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—IL2—acquired immunodeficiency syndrome	0.000234	0.00167	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—HLA-B—acquired immunodeficiency syndrome	0.000232	0.00166	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—IFNG—acquired immunodeficiency syndrome	0.00023	0.00164	CbGpPWpGaD
Minocycline—CASP1—Immune System—MBL2—acquired immunodeficiency syndrome	0.000229	0.00163	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	0.000225	0.0016	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000224	0.0016	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	0.00022	0.00157	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000209	0.00149	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	0.000208	0.00149	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	0.000205	0.00146	CbGpPWpGaD
Minocycline—VEGFA—Differentiation Pathway—IL6—acquired immunodeficiency syndrome	0.000205	0.00146	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TNF—acquired immunodeficiency syndrome	0.000204	0.00146	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—IL2—acquired immunodeficiency syndrome	0.000204	0.00146	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000202	0.00144	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.000198	0.00141	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	0.000195	0.00139	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	0.000194	0.00139	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—TAT—acquired immunodeficiency syndrome	0.000192	0.00137	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.000189	0.00135	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000186	0.00133	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	0.000186	0.00132	CbGpPWpGaD
Minocycline—CASP1—Immune System—CCR2—acquired immunodeficiency syndrome	0.000179	0.00128	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—IL6—acquired immunodeficiency syndrome	0.000176	0.00126	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—IL6—acquired immunodeficiency syndrome	0.000174	0.00124	CbGpPWpGaD
Minocycline—IL1B—Immune System—ACTG1—acquired immunodeficiency syndrome	0.000174	0.00124	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—TNF—acquired immunodeficiency syndrome	0.00017	0.00122	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000168	0.0012	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	0.000165	0.00118	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TNF—acquired immunodeficiency syndrome	0.000165	0.00118	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—IL6—acquired immunodeficiency syndrome	0.000164	0.00117	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000164	0.00117	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	0.000164	0.00117	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000164	0.00117	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—TNF—acquired immunodeficiency syndrome	0.000163	0.00116	CbGpPWpGaD
Minocycline—CASP1—Immune System—IFNA1—acquired immunodeficiency syndrome	0.000161	0.00115	CbGpPWpGaD
Minocycline—IL1B—Signaling by Interleukins—IL6—acquired immunodeficiency syndrome	0.000161	0.00115	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.00016	0.00114	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD79A—acquired immunodeficiency syndrome	0.000157	0.00112	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000155	0.0011	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	0.00015	0.00107	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	0.000148	0.00106	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IFNG—acquired immunodeficiency syndrome	0.000144	0.00102	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000143	0.00102	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000143	0.00102	CbGpPWpGaD
Minocycline—IL1B—Immune System—MBL2—acquired immunodeficiency syndrome	0.000143	0.00102	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000142	0.00102	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	0.000142	0.00102	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.00014	0.000998	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	0.00014	0.000995	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.000132	0.000944	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—IL6—acquired immunodeficiency syndrome	0.000131	0.000937	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000129	0.000924	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.000128	0.000913	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD40LG—acquired immunodeficiency syndrome	0.000128	0.000911	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL2—acquired immunodeficiency syndrome	0.000128	0.000911	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	0.000127	0.000904	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD8A—acquired immunodeficiency syndrome	0.000126	0.000901	CbGpPWpGaD
Minocycline—CASP1—Immune System—CSF2—acquired immunodeficiency syndrome	0.000126	0.000901	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CD4—acquired immunodeficiency syndrome	0.000124	0.000888	CbGpPWpGaD
Minocycline—CASP1—Immune System—HLA-B—acquired immunodeficiency syndrome	0.000121	0.000866	CbGpPWpGaD
Minocycline—IL1B—Myometrial Relaxation and Contraction Pathways—IL6—acquired immunodeficiency syndrome	0.00012	0.000859	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	0.00012	0.000857	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.00012	0.000855	CbGpPWpGaD
Minocycline—SLC22A11—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.000119	0.000846	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.000116	0.000829	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	0.000115	0.00082	CbGpPWpGaD
Minocycline—IL1B—Immune System—CCR2—acquired immunodeficiency syndrome	0.000112	0.000799	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—IL6—acquired immunodeficiency syndrome	0.000108	0.000769	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—IL6—acquired immunodeficiency syndrome	0.000108	0.000768	CbGpPWpGaD
Minocycline—SLC22A7—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.000108	0.000768	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	0.000103	0.000733	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—IL6—acquired immunodeficiency syndrome	0.000102	0.000726	CbGpPWpGaD
Minocycline—IL1B—Immune System—IFNA1—acquired immunodeficiency syndrome	0.000101	0.000719	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.0001	0.000715	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—IL6—acquired immunodeficiency syndrome	9.96e-05	0.000711	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	9.94e-05	0.000709	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	9.94e-05	0.000709	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	9.88e-05	0.000705	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD79A—acquired immunodeficiency syndrome	9.79e-05	0.000698	CbGpPWpGaD
Minocycline—SLC22A8—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	9.05e-05	0.000645	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	8.99e-05	0.000641	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	8.85e-05	0.000631	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	8.63e-05	0.000616	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	8.63e-05	0.000616	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	8.41e-05	0.0006	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—IL6—acquired immunodeficiency syndrome	8.15e-05	0.000581	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8e-05	0.000571	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD40LG—acquired immunodeficiency syndrome	7.98e-05	0.000569	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	7.98e-05	0.000569	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD8A—acquired immunodeficiency syndrome	7.89e-05	0.000563	CbGpPWpGaD
Minocycline—IL1B—Immune System—CSF2—acquired immunodeficiency syndrome	7.89e-05	0.000563	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	7.8e-05	0.000557	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-B—acquired immunodeficiency syndrome	7.59e-05	0.000541	CbGpPWpGaD
Minocycline—SLC22A6—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	7.55e-05	0.000539	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	7.53e-05	0.000537	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.52e-05	0.000537	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.52e-05	0.000537	CbGpPWpGaD
Minocycline—CASP1—Immune System—IFNG—acquired immunodeficiency syndrome	7.51e-05	0.000536	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	7.5e-05	0.000535	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD4—acquired immunodeficiency syndrome	7.25e-05	0.000517	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—IL6—acquired immunodeficiency syndrome	6.73e-05	0.00048	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL2—acquired immunodeficiency syndrome	6.67e-05	0.000476	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—ALB—acquired immunodeficiency syndrome	6.53e-05	0.000466	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	6.14e-05	0.000438	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	6.03e-05	0.00043	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.72e-05	0.000408	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.64e-05	0.000402	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	5.55e-05	0.000396	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	5.47e-05	0.00039	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ALB—acquired immunodeficiency syndrome	5.44e-05	0.000388	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	5.33e-05	0.00038	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IL2—acquired immunodeficiency syndrome	5.29e-05	0.000378	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—IL6—acquired immunodeficiency syndrome	5.24e-05	0.000374	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	5.22e-05	0.000372	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	5.22e-05	0.000372	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.15e-05	0.000368	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—IL6—acquired immunodeficiency syndrome	5.12e-05	0.000365	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	4.82e-05	0.000344	CbGpPWpGaD
Minocycline—IL1B—Immune System—IFNG—acquired immunodeficiency syndrome	4.69e-05	0.000335	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	4.6e-05	0.000328	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	4.53e-05	0.000323	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	4.53e-05	0.000323	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD4—acquired immunodeficiency syndrome	4.53e-05	0.000323	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TNF—acquired immunodeficiency syndrome	4.53e-05	0.000323	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—IL6—acquired immunodeficiency syndrome	4.45e-05	0.000317	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL2—acquired immunodeficiency syndrome	4.17e-05	0.000297	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.97e-05	0.000283	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TNF—acquired immunodeficiency syndrome	3.93e-05	0.00028	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL6—acquired immunodeficiency syndrome	3.92e-05	0.00028	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.91e-05	0.000279	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.84e-05	0.000274	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—IL6—acquired immunodeficiency syndrome	3.65e-05	0.000261	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.58e-05	0.000255	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.45e-05	0.000246	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.4e-05	0.000242	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ALB—acquired immunodeficiency syndrome	3.35e-05	0.000239	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—IL6—acquired immunodeficiency syndrome	3.17e-05	0.000226	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.11e-05	0.000222	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.98e-05	0.000212	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL6—acquired immunodeficiency syndrome	2.45e-05	0.000175	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.07e-05	0.000148	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.79e-05	0.000128	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.75e-05	0.000125	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.22e-05	8.67e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.05e-05	7.53e-05	CbGpPWpGaD
